Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (Q6)Jun 30, 2025 | (FY)Dec 31, 2024 | (Q6)Jun 30, 2024 | (FY)Dec 31, 2023 | (Q6)Jun 30, 2023 | (FY)Dec 31, 2022 | (Q6)Jun 30, 2022 | (FY)Dec 31, 2021 | |
|---|---|---|---|---|---|---|---|---|
| Operating income | ||||||||
| Operating expenses | ||||||||
| Gross profit | ||||||||
| Administrative expenses | 53.04%-21.63M | 40.57%-81.23M | 11.46%-46.05M | -214.67%-136.67M | -83.43%-52.01M | 9.64%-43.43M | ---28.36M | ---48.06M |
| Research and development expenses | 47.31%-106.41M | -16.68%-363.53M | -68.19%-201.97M | -70.58%-311.57M | -57.34%-120.09M | -117.41%-182.65M | ---76.32M | ---84.01M |
| Revaluation surplus | ---- | ---- | ---- | -2,346.62%-522.16M | -1,378.95%-399.64M | 123.65%23.24M | --31.25M | ---98.27M |
| -Changes in the fair value of other assets | ---- | ---- | ---- | -2,346.62%-522.16M | -1,378.95%-399.64M | 123.65%23.24M | --31.25M | ---98.27M |
| Special items of operating profit | -58.63%15.76M | 105.18%64.77M | 71.48%38.1M | 141.65%31.57M | 4,972.81%22.22M | -5.48%13.06M | ---456K | --13.82M |
| Operating profit | 46.52%-112.28M | 59.53%-379.99M | 61.80%-209.93M | -394.70%-938.83M | -643.72%-549.52M | 12.35%-189.78M | -73.89M | -216.52M |
| Financing cost | -227.65%-1.58M | -283.50%-1.53M | -139.30%-481K | 6.10%-400K | 7.37%-201K | 90.59%-426K | ---217K | ---4.53M |
| Earning before tax | 45.89%-113.85M | 59.38%-381.52M | 61.72%-210.41M | -393.80%-939.23M | -641.81%-549.72M | 13.95%-190.21M | -74.11M | -221.05M |
| Tax | 98.88%-6K | -253.95%-269K | -1,969.23%-538K | -137.50%-76K | 63.89%-26K | 66.67%-32K | ---72K | ---96K |
| After-tax profit from continuing operations | 46.03%-113.86M | 59.35%-381.79M | 61.63%-210.95M | -393.76%-939.31M | -641.12%-549.74M | 13.98%-190.24M | -74.18M | -221.15M |
| Earning after tax | 46.03%-113.86M | 59.35%-381.79M | 61.63%-210.95M | -393.76%-939.31M | -641.12%-549.74M | 13.98%-190.24M | -74.18M | -221.15M |
| Minority profit | --6.46M | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
| Profit attributable to shareholders | 42.96%-120.32M | 59.35%-381.79M | 61.63%-210.95M | -393.76%-939.31M | -641.12%-549.74M | 13.98%-190.24M | -74.18M | -221.15M |
| Basic earnings per share | 42.55%-0.27 | 76.80%-0.84 | 78.24%-0.47 | -382.67%-3.62 | -23.43%-2.16 | 85.74%-0.75 | -1.75 | -5.26 |
| Diluted earnings per share | 42.55%-0.27 | 76.80%-0.84 | 78.24%-0.47 | -382.67%-3.62 | -23.43%-2.16 | 85.74%-0.75 | -1.75 | -5.26 |
| Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
| Accounting Standards | IAS | IAS | IAS | IAS | IAS | IAS | IAS | IAS |
| Audit Opinions | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion |
| Auditor | -- | Dahua Ma Shiyun Certified Public Accountants Co., Ltd. | -- | Ernst & Young | -- | Ernst & Young | -- | Ernst & Young |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.